Psilos Group

Psilos Group

Signal active

Investment Firm

Overview

Psilos has established itself as a successful healthcare investor and has demonstrated its ability to effectively identify and analyze attractive investment opportunities, to structure and consummate high-quality transactions and to work with entrepreneurial management teams from company inception to successful liquidity events. They understand entrepreneurial drive and the importance of developing relationships with companies that reinforce management's creative energies. Psilos seeks investments where they can have a significant positive impact on the strategic development of their portfolio companies, leveraging their broad network of relationships with both strategic and financial investors, corporate partners, investment banks, and industry leaders across the healthcare field. Psilos invests in businesses that are poised to establish enduring market value by developing fundamental improvements in the healthcare system as a whole. Psilos seeks to be the lead investor in companies that have: • An industry-transforming service, technology or product idea; • A strong, experienced and visionary management team; • Broad applicability to a large and growing market; • A compelling and sound business model with superior returns potential; • Strong intellectual property and high barriers to entry; and, • Entrepreneurs desirous of forming a strong partnership with their investors

Highlights

Founded

1998

Industry

Venture Capital

Employees

1-10

Investment

37

Lead Investment

18

Exits

16

Stages

Late Stage Venture, Early Stage Venture

Investor Type

Micro Vc

Location

New York, New York, United States, North America

Contact Information

Social

Profile Resume

Psilos Group, established in 1998 and headquartered in New York, New York, United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Health Care, Medical Device, Robotics, Information Technology, Financial Services, Venture Capital, Finance, Infrastructure, Banking, Biotechnology. The organization boasts a portfolio of 37 investments, with an average round size of $18.5M and 16 successful exits. Their recent investments include OmniGuide, 3i Group, AngioScore, Pelion Venture Partners, QuestMark Partners. The highest investment round they participated in was $45.8B. Among their most notable exits are OmniGuide and 3i Group. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Albert S. Waxman

Albert S. Waxman

Senior Managing Member & CEO

Investment portfolio

Psilos Group has made 37 investments. Their most recent investment was on Sep 25, 2017, when PatientSafe Solutions raised $25.0M.

Psilos Group has made 1 diversity investments. Their most recent diversity investment was on Jun 28, 2000, when eMotion raised $34.0M.

investments

37

Diversity investments

1

Lead investments

18

Number of exits

16

Investments

37

Annouced DateOrganization NameIndustryMoney Raised
Jul 16, 2013
Gamma Medica Gamma Medica
Biotechnology16.0M
Sep 24, 2013
PatientSafe Solutions PatientSafe Solutions
Software7.0M
Oct 22, 2014
Gamma Medica Gamma Medica
Biotechnology5.0M
Sep 25, 2017
PatientSafe Solutions PatientSafe Solutions
Software25.0M

Exits

16

Funding Timeline

Funding rounds

37

Investors

0

Funds

2

Funding Rounds

37

Psilos Group has raised 37 rounds. Their latest funding was raised on Sep 25, 2017 from a Venture Round - PatientSafe Solutions round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jul 16, 2013
Series A - Gamma Medica Series A - Gamma Medica
-16.0M-
Sep 24, 2013
Series C - PatientSafe Solutions Series C - PatientSafe Solutions
-7.0M-
Oct 22, 2014
Series B - Gamma Medica Series B - Gamma Medica
-5.0M-
Sep 25, 2017
Venture Round - PatientSafe Solutions Venture Round - PatientSafe Solutions
-25.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.